BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 38125796)

  • 1. Advances in targeted therapy and biomarker research in thyroid cancer.
    Guo M; Sun Y; Wei Y; Xu J; Zhang C
    Front Endocrinol (Lausanne); 2024; 15():1372553. PubMed ID: 38501105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of cervical lymph nodes in differentiated thyroid cancer.
    Fritze D; Doherty GM
    Otolaryngol Clin North Am; 2010 Apr; 43(2):285-300, viii. PubMed ID: 20510715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pro and contra lymphadenectomy in papillary and follicular thyroid gland carcinoma].
    Seiler CA; Schäfer M; Büchler MW
    Zentralbl Chir; 2000; 125(10):835-40; discussion 840-1. PubMed ID: 11098579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients.
    Liang N; Zhang H; Sui C; Du R; Li C; Li J; Dionigi G; Zhang D; Sun H
    Front Endocrinol (Lausanne); 2023; 14():1301620. PubMed ID: 38125796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
    Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
    Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
    Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
    Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer.
    Miller JE; Al-Attar NC; Brown OH; Shaughness GG; Rosculet NP; Avram AM; Hughes DT
    Thyroid; 2018 May; 28(5):593-600. PubMed ID: 29562827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of differentiated thyroid carcinoma in children.
    Bingöl-Koloğlu M; Tanyel FC; Senocak ME; Büyükpamukçu N; Hiçsönmez A
    Eur J Pediatr Surg; 2000 Dec; 10(6):347-52. PubMed ID: 11215773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the risk of re-recurrence in patients with persistent/recurrent thyroid carcinoma after initial reoperation.
    Xu S; Li Q; Wang Z; Huang H; Wang X; Liu S; Liu J
    Surgery; 2021 Apr; 169(4):837-843. PubMed ID: 33127094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperations for structurally persistent or recurrent disease after thyroidectomy: analysis via preoperative CT.
    Kim HK; Ha EJ; Han M; Lee J; Soh EY
    Sci Rep; 2020 Jul; 10(1):12376. PubMed ID: 32704006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous laryngeal ultrasonography: a reliable, non-invasive and inexpensive preoperative method in the evaluation of vocal cords motility-a prospective multicentric analysis on a large series and a literature review.
    Gambardella C; Offi C; Romano RM; De Palma M; Ruggiero R; Candela G; Puziello A; Docimo L; Grasso M; Docimo G
    Updates Surg; 2020 Sep; 72(3):885-892. PubMed ID: 32124271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.
    Patel KN; Yip L; Lubitz CC; Grubbs EG; Miller BS; Shen W; Angelos P; Chen H; Doherty GM; Fahey TJ; Kebebew E; Livolsi VA; Perrier ND; Sipos JA; Sosa JA; Steward D; Tufano RP; McHenry CR; Carty SE
    Ann Surg; 2020 Mar; 271(3):e21-e93. PubMed ID: 32079830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adjuvant therapy with radioactive iodine in patients with elevated serum thyroglobulin after neck reoperation due to recurrent papillary thyroid cancer: a monoinstitutional comparative study.
    Weslley Rosario P; Franco Mourão G; Regina Calsolari M
    Endocrine; 2020 Apr; 68(1):144-150. PubMed ID: 31865556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer.
    Bouvet C; Barres B; Kwiatkowski F; Batisse-Lignier M; Chafai El Alaoui M; Kauffmann P; Cachin F; Tauveron I; Kelly A; Maqdasy S
    Front Endocrinol (Lausanne); 2019; 10():671. PubMed ID: 31611847
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.